Bionano Genomics- Warrants (21/08/2023) Current Assets

Bionano Genomics- Warrants (21/08/2023) (BNGOW) currently reports a current assets of $25M as of June 2026. That compares with $43M in the prior-year period — down 41.7% year over year. Use the charts on this page to explore Bionano Genomics- Warrants (21/08/2023)'s current assets history and peer comparisons.

Bionano Genomics- Warrants (21/08/2023)'s current assets decreased from $43M to $25M — a 41.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bionano Genomics- Warrants (21/08/2023) reported $25M in current assets as of June 2026. That compares with $43M in the prior-year period — down 41.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bionano Genomics- Warrants (21/08/2023), and consider following BNGOW for alerts when major investors trade the stock.

Bionano Genomics- Warrants (21/08/2023) is classified in the Healthcare sector. On current assets, it currently shows $25M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNGOW with unrelated industries.